BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29756363)

  • 1. Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of different pathologic tumor subcategories.
    Succo G; Crosetti E; Bertolin A; Piazza C; Molteni G; Cirillo S; Petracchini M; Tascone M; Sprio AE; Berta GN; Peretti G; Presutti L; Rizzotto G
    Head Neck; 2018 Sep; 40(9):1897-1908. PubMed ID: 29756363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of recurrence after open partial horizontal laryngectomy types II and III: univariate and logistic regression analysis of risk factors.
    Crosetti E; Bertolin A; Molteni G; Bertotto I; Balmativola D; Carraro M; Sprio AE; Berta GN; Presutti L; Rizzotto G; Succo G
    Acta Otorhinolaryngol Ital; 2019 Aug; 39(4):235-243. PubMed ID: 31501615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and drawbacks of open partial horizontal laryngectomies, Part A: Early- to intermediate-stage glottic carcinoma.
    Succo G; Crosetti E; Bertolin A; Lucioni M; Caracciolo A; Panetta V; Sprio AE; Berta GN; Rizzotto G
    Head Neck; 2016 Apr; 38 Suppl 1():E333-40. PubMed ID: 25581514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Re-evaluation of 191 larynx cancer surgeries according to the Open Partial Horizontal Laryngectomies classification proposed by European Laryngological Society working committee in 2014].
    Wierzbicka M; Leszczyńska M; Szyfter W
    Otolaryngol Pol; 2014; 68(6):281-6. PubMed ID: 25152380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supracricoid partial laryngectomy in the management of t3 laryngeal cancer.
    Mercante G; Grammatica A; Battaglia P; Cristalli G; Pellini R; Spriano G
    Otolaryngol Head Neck Surg; 2013 Nov; 149(5):714-20. PubMed ID: 23921496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and drawbacks of open partial horizontal laryngectomies, Part B: Intermediate and selected advanced stage laryngeal carcinoma.
    Succo G; Crosetti E; Bertolin A; Lucioni M; Arrigoni G; Panetta V; Sprio AE; Berta GN; Rizzotto G
    Head Neck; 2016 Apr; 38 Suppl 1():E649-57. PubMed ID: 25866908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
    Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supratracheal laryngectomy: current indications and contraindications.
    Succo G; Bussi M; Presutti L; Cirillo S; Crosetti E; Bertolin A; Giordano L; Molteni G; Petracchini M; Sprio AE; Berta GN; Fornari A; Rizzotto G
    Acta Otorhinolaryngol Ital; 2015 Jun; 35(3):146-56. PubMed ID: 26246658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control?
    Nakayama M; Miyamoto S; Seino Y; Okamoto T; Kano K; Hasebe M; Okamoto M
    Jpn J Clin Oncol; 2015 Aug; 45(8):732-7. PubMed ID: 25981622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
    Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
    Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
    Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
    Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
    Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
    Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
    Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after supracricoid laryngectomies in the material of ENT Department, Poznan University of Medical Sciences.
    Szyfter W; Leszczyńska M; Wierzbicka M
    Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):879-83. PubMed ID: 21305310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome of the treatment for laryngeal carcinoma by partial laryngectomies].
    Pajor A; Kopczyński J; Gryczyński M
    Otolaryngol Pol; 2004; 58(4):757-64. PubMed ID: 15603386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arytenoid Fixation in Laryngeal Cancer: Radiological Pictures and Clinical Correlations with Respect to Conservative Treatments.
    Succo G; Cirillo S; Bertotto I; Maldi E; Balmativola D; Petracchini M; Gned D; Fornari A; Motatto GM; Sprio AE; Manca A; Crosetti E
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871238
    [No Abstract]   [Full Text] [Related]  

  • 17. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma.
    Bron LP; Soldati D; Monod ML; Mégevand C; Brossard E; Monnier P; Pasche P
    Eur Arch Otorhinolaryngol; 2005 Apr; 262(4):302-6. PubMed ID: 15316823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes of surgical treatment for T3 glottic laryngeal squamous cell carcinoma.
    Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
    Head Neck; 2018 Aug; 40(8):1734-1742. PubMed ID: 29601122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictable swallowing function after open horizontal supraglottic partial laryngectomy.
    Breunig C; Benter P; Seidl RO; Coordes A
    Auris Nasus Larynx; 2016 Dec; 43(6):658-65. PubMed ID: 26853312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2N0 invading the anterior commissure.
    Laccourreye O; Muscatello L; Laccourreye L; Naudo P; Brasnu D; Weinstein G
    Am J Otolaryngol; 1997; 18(6):385-90. PubMed ID: 9395014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.